Logo

Med BioGene Taps JRG for Strategic Advice to Help Launch Cancer Dx

Oct 25, 2007
NEW YORK (GenomeWeb News) — Med BioGene said today that it has hired JRG Ventures for strategic business advice as it moves to commercialize a new genomic-based diagnostic test for lymphoma.
 
JRG will help the company define its partnering and commercialization strategy as it prepares to roll out its clinical laboratory LymphExpress Dx test.
 
JRG advises companies involved in life sciences, healthcare, and information technology, partnering, licensing, corporate and regulatory strategies, and operations and logistics.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.